Bone marrow-derived (B) lymphocytes in man and mouse have characteristic cell surface markers, such as immunoglobulin, that distinguish this subpopulation from other types of lymphocytes (1) (2) (3) (4) . In the mouse, thymus-derived (T) lymphoeytes also have cell markers, such as theta antigen (Thy 1.2) and Ly antigens, that typify this cell type (5) (6) (7) . In contrast, human T-cell surface markers are not as well delineated. T lymphocytes have receptors for and form rosettes with unsensitized sheep erythrocytes (SRBC) t and display a differentiation marker, human T lymphocyte antigen (HTLA) (8) (9) (10) . The chemical nature of both the SRBC receptor and HTLA are not well defined.
We have previously shown that a protein, termed macromolecular insoluble cold globulin (MICG), is an exclusive product ofT cells in the mouse (11) (12) (13) . The name MICG has been used to describe the major physicochemical properties of this protein.
It has a mol wt of 225,000 daltons, is insoluble in the cold in nonionic detergents, and migrates as a fl-globulin on electrophoresis. The present communication describes the characterization of an analogous protein in human T cells, termed T-MICG. We further demonstrate a protein in null (N) cells, termed N-MICG, which has similar physical properties to, but differs antigenically from, T-MICG.
Materials and Methods

Isolation of Human Lymphocytes and Subpopulations. Peripheral blood mononuclear cells (PBL)
were separated from 100 ml of heparinized whole blood by Ficoll-Hypaque centrifugation (FHC) (14) . The PBL were depleted of monocytes by adherence to plastic Petri dishes for 1 h at 37°C (15) . Morphological examination of these cells 0Nright-Giemsa staining of smears) demonstrated a mean of 98% lymphocytes and 2% monocytes. They are subsequently referred to as lymphocytes. T cells in these preparations were enumerated by rosette formation with SRBC and separated from PBL by rosette sedimentation (9, 16) . Briefly, fresh SRBC (Grand Island Biological Co., Grand Island, N. Y.) are washed in phosphate-buffered saline (PBS) and resuspended to a concentration of 5% in Hanks' Balanced Salt Solution (HBSS) (Grand Island Biological Co.). 1 ml of neuraminidase (Behring Diagnostics, Somerville, N. J.), diluted to 0.5 U/ml in HBSS, is added to 1 ml of 5% SRBC. The mixture is incubated for 30 min at 37°C, i Abbreviations used in this paper." FHC, Ficoll-Hypaque centrifugation; FITC, fluorescein isothiocyanate; HBSS, Hanks' balanced salt solution; HTLA, human T lymphocyte antigen; MICG, macromolecular insoluble cold globulin; N, null; NP-40, Nonidet P-40; PAGE, polyacrylamide gel electrophoresis; PBL, peripheral blood mononuclear cells; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate; SRBC, sheep erythrocytes.
washed with RPMI-1640 (Grand Island Biological Co.), and diluted to 0.5% SRBC. To a 0.5-ml suspension of 0.5% SRBC is added 0.5 ml of a lymphocyte suspension containing 2 × 106 cells/ml. The mixture is incubated at 37°C for 15 rain, centrifuged at 200 g for 5 min at room temperature, and placed at 4°C for 60 rain. The tubes are then inverted and the cells stained with 0.5% toluidine blue and placed in a hemocytometer and 200 lymphocytes counted and expressed as the percent of E rosettes, i.e., percent of iymphocytes forming rosettes with SRBC (three or more). After PBL were rosetted with SRBC, the cell mixture was subjected to a second FHC. The pellet, containing free SRBC and E rosettes, was incubated at 37°C for 15 min to dissociate the rosettes and then either hypotonically lysed in deionized water or subjected to another FHC. These cells are referred to as T-lymphocytes (E+). This subpopulation contained less than 2% surface immunoglobulin-positive cells (SIg +) and 97% of these cells formed rosettes with SRBC, i.e., E +. The lymphocyte fraction at the Ficoll-medium interphase of the second FHC was rerosetted with SRBC and subjected to a third FHC. Unrosetted cells at the Ficollmedium interphase of this last separation were referred to as B-enriched lymphocytes and contained 70-80% SIg + cells and less than 2% E + cells. Fluorescent microscopy, using fluorescein isothiocyanate (FITC) conjugated rabbit anti-human-Fab (Behring Diagnostics) was performed to identify SIg + cells, i.e., B cells (17) . B cells were also enumerated by rosetting with SRBC coated with antibody (IgM) and complement (EAC) (18) . To enumerate lymphocytes forming rosettes with EAC, 0.5 ml of PBL (2 × 10e/mi) was added to 0.5 ml of 0.5% EAC. This mixture was incubated for 30 rain at 37°C with agitation. The rosettes formed were quantitated as above. B-enriched lymphocytes quantitated by this technique were 70-75% EAC positive.
Purified B iymphocytes were isolated utilizing rabbit anti-human-Fab columns as described by Chess et al. (19, 20) . In this procedure, isolated antibody to human Fab is linked to cyanogen bromide activated Sephadex G-200. The cells (200 × 10") applied to this column were either PBL or B-enriched cells from the Ficoll-medium interphase after E-rosette sedimentation. In the case of PBL, unbound cells, consisting ofT (E +) and N (SIg-and E-) cells are collected and bound cells eluted by competitive inhibition with human IgG (21) . The bound-cell fraction contains 98% SIg + cells and is referred to as B cells, while the unbound cells contain 82% E + cells and < 2% SIg + cells.
Isolation of N cells from PBL and B-enriched lymphocytes is described in the text.
Cell Culture Conditions for Protein Synthesis in Human Lymphocytes.
Single cell suspensions of PBL, T cells, B cells, or N cells (10-50 × 10 s) were incubated in 3 ml of Eagle's minimal essential medium minus leucine (Grand Island Biological Co.), without fetal calf serum, with 10 #Ci of [14C]leucine, sp act 298 mCi/mmol, (New England Nuclear, Boston, Mass.) as previously described (12) . The cells were incubated for 4 h at 37°C in a mixture of 95% air-5% CO2 in a humidified atmosphere (22, 23) . After incubation, cell viability was determined with 0.05% (vol/vol) trypan blue in PBS and only cultures with greater than 95% viability further utilized. The radiolabeled cells were then immersed in ice water, made 0.06 M in iodoacetamide, and centrifuged at 400 g for 10 min. The cells were washed in Eagle's complete medium four times at 4°C, resuspended in isotonic buffer (22) , containing 0.5% Nonidet (NP-40) (Particle Data Lab. Ltd., Elmhurst, Ill.), 0.06 M iodoacetamide and 1,000 U/ml ofTrasyloi (Calbiochem, San Diego, Calif.). Detergent lysis was allowed to occur at 4°C for 20 min, and the resultant cell lysate centrifuged at 105,000 g for 30 min at 4°C, and the pellet discarded.
Isolation of MICG by Cold Precipitation. Cell lysates were incubated for 2 days at 4°C, centrifuged at 25,000 g for 20 rain, and the precipitate vigorously washed three times in cold PBS. These conditions were found to be optimal for cold precipitation (12) Preparation of Antisera. New Zealand white rabbits were used to raise all antisera (12) .
Homogenous T-MICG, N-MICG, or a combination of T and N-MICG was prepared by cold precipitation of isolated T and/or N-cell lysates. Homogeneity was assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and gel filtration on a Biogel A-5M column (0.9 cm × 90 cm) equilibrated with 1% SDS-buffer (12) . The isolated proteins used for immunization were solubilized in Triton-urea buffer. Antiserum to human IgM, IgA, IgG, albumin, transferrin, and az macroglobulin have been previously described (24, 25) . These antiserum were monospecific by immunoelectrophoresis and Ouchterlony analysis using normal human plasma and serum as antigen, as well as concentrated fractions of isolated serum proteins. In addition, specificity of antiserum was shown by radioimmunoassay (1) . All antisera were heat inactivated at 56°C for 30 rain before use. The antiserum are referred to in the text as anti-T-MICG, i.e., antiserum to T-cell derived MICG (T-MICG); anti-N-MICG, i.e., antiserum to N-cell derived MICG (N-MICG); or anti-CF + N)-MICG, i.e., a single antiserum to both T and N-cellderived MICG.
Radioiodination of Lymphocyte Lysates. Cold precipitates of PBL lysates were deliberately not washed, to obtain contamination of the cryoprecipitate with other lymphocyte associated proteins. The contaminated precipitate was dissolved in 0.5% Triton-2 M urea-Tris buffer pH 8.1. The dissolved proteins were then radioiodinated with a2Sl (New England Nuclear) by the Chloramine T method as previously described (26, 27 ). An aliquot of this sample was directly electrophoresed or immune precipitated before SDS-PAGE.
Immune Precipitation. Radioiodinated samples were immune precipitated with antiserum to MICG (250/tl) in antibody excess and incubated at 37°C for 16 h. The precipitates were washed three times in cold PBS, dissolved in SDS-urea buffer, and incubated at 37°C for 30 min. In some experiments, radioiodinated lysates were precipitated with anti-T-MICG and the supernate of this precipitate divided into two equal aliquots. One portion was treated with anti-T-MICG and the other with anti-N-MICG. In these experiments the first antiserum always depleted the protein to which it was directed.
SDS-PAGE.
Solubilized cold and immune precipitates were reduced with 0.5 M 2-mercaptoethanol for 1 h at 37°C, alkylated with 0.65 M iodoaeetamide, and then dialyzed against 0.01 M phosphate buffer pH 7.0, 0.1% with respect to SDS (0.1% SDS buffer). The samples were eleetrophoresed on 5% PAGE in 0.1% SDS for 31/2 h at 8 ma per gel (28) . The gels were frozen at -70°C and sliced into 1-mm sections and the radioactivity eluted overnight at 37°C in 0.1% SDS-buffer. 5 ml of Aquasol (New England Nuclear) was added after the over night incubation and the samples counted in a liquid scintillation spectrometer. Marker proteins for molecular weight determination of samples were simultaneously electrophoresed on companion gels and stained (12) . Alternatively, IgM and IgG were isolated by immune precipitation of [14C]leucine labeled mouse plasmacytoma cells of the appropriate class. The radiolabeled markers were reduced and electrophoresed on companion gels, which were sliced and counted (12) . Intracellular 8 S IgM (200,000 dahons) was immunoprecipitated from MOPC 104E-labeled lysates and electrophoresed in the unreduced state. Standard curves for molecular weight were constructed for each electrophoretic run and the values given are means of at least three separate determinations.
Cytotoxicity. Lymphocyte cell suspensions were washed in McCoy's medium (Grand Island
Biological Co.) and cytotoxicity measured in microtiter plates employing eosin dye incorporation to determine cell death (29, 30) . To 2,000 cells in 1 bd of McCoy's medium containing 5% fetal calf serum was added 1 /.d of rabbit antiserum or normal rabbit serum. The cells were incubated at room temperature for 30 min and then 5 pl of rabbit complement (Grand Island Biological Co.) was added to each well and incubation continued for 2 h at room temperature. Eosin dye was added and each well scored for the number of cells incorporating dye (cell death) in the following manner: 1 = 0-10%; 2 --11-20%; 3 = 21-30%; 4 = 31-50%; 5 = 51-70%; 6 = 71-80%; 7 = 81-90%; and 8 >91%. Controls in these experiments consisted of normal rabbit serum and rabbit anti-human albumin antiserum, or medium. These sera showed no cytotoxicity in the presence or absence of rabbit complement. The rabbit complement did not induce cell death when incubated with lymphocytes in the absence of antiserum.
Immunofluorescence of Lymphocyte Plasma Membrane. Indirect immunofluorescence was performed on viable PBL and subpopulations obtained from anti-Fab columns (31, 32) . Lymphocytes (2 × 10 n) were incubated for 1 h at 37°C in 3 ml Eagle's minimal essential medium supplemented with 20% fetal calf serum and 0.2% sodium azide. The cells were washed, resuspended in 0.1 ml of medium, and incubated at 4°C for 30 min with 0.1 ml of anti-(T + N)-MICG antiserum (1:64). The antiserum employed was the IgG fraction, heat inactivated at 56°C and adsorbed with calf liver powder before use. In some experiments the rabbit IgG was digested with pepsin to produce an Fab2 T-fragment, as previously shown (33) . The cells were washed three times in medium, resuspended in 0.1 ml of medium, and 0.1 ml of FITC conjugated goat anti-rabbit IgG (Behring Diagnostics) (1:32) added. Incubation was continued for 30 min at 4°C, the cells washed three times, and finally resuspended in 0.1 ml of medium.
A drop of the cell suspension was applied to a microscope slide with the bottom of a 12 x 75 mm test tube, fixed in ethanol (95%) and a cover slip applied in buffered glycerol (34) . Direct immunofluorescence was also performed on viable lymphocytes utilizing FITC conjugated rabbit anti-human-Fab antiserum (Behring Diagnostics). Lymphocytes, 2 X 106/0.1 ml of medium, were incubated with a 1:16 dilution of antiserum for 30 rain at 4°C and processed as in the indirect technique.
The preparations were examined with a Zeiss IV FL-epifluorescent microscope equipped with an Osram 12 V, 100 W, halogen lamp and an incident-light fluorescence illuminator. The following combination of exciting and barrier filters and of beam splitters were used: for visualization of fluorescein, exciting filter 450-490 nm, barrier filter LP 520, beam splitter FT 510. The same field of cells was also examined by phase contrast microscopy. Photographs were recorded on Ektachrome ASA 200 film. Indirect specificity controls consisted of normal rabbit serum, in place of anti-(T + N)-MICG, and absorption experiments. Less than 1% PBL were immunofluorescent positive at 1:2 dilution of normal rabbit IgG (1 mg/ml). Indirect fluorescence was completely blocked by absorption of anti-(T + N)-MICG with either PBL, T + N cells (300 X 10e/0.5 ml of antibody) or T + N-MICG antigen (45 #g). Indirect immunofluorescence was also blocked by adsorption of FITC goat anti-rabbit IgG with rabbit IgG. There was no inhibition of immunofluorescence when anti-(T + N)-MICG antiserum was adsorbed with lyophilized human plasma (20 mg/ml), normal B cells, or chronic lymphocytic leukemia cells at cell concentrations of 300 X 106/0.5 ml of antibody.
Results
Isolation and Characterization of MICG Proteins from Human Lymphocytes.
When radiolabeled lysates from PBL were cold precipitated, SDS-PAGE demonstrated two macromolecules with mol wt of 225,000 and 185,000 daltons, accounting for 90 and 10%, respectively, of the cryoprecipitate (Fig. 1 a) . Incubation of cell lysates for 48 h at 22°C did not induce the precipitation of MICG-like proteins. Similar to mouse MICG, both macromolecules had the electrophoretic mobility of fl-globulins (12) . Cryoprecipitate analyzed by SDS-PAGE, and stained for protein with Coomasie Blue is shown in Fig. 2 a. Using suitable standards, the mol wt of the two major proteins were calculated to be 225,000 and 185,000 daltons, similar to the radiolabeled preparations. Although a small amount of contamination is present in this gel, a homogenous protein can be obtained by thorough washing of the cold precipitate.
Analysis of cold precipitates from T and B-enriched cells, isolated by rosette sedimentation, showed that the T lymphocytes synthesized the 225,000 dalton protein, while the B-enriched cells synthesized the 185,000 dalton macromoleeule (Figs. 1 b, 1 c  and 2b, 2c) . In four separate experiments with different histocompatability typed lymphocytes, neither cell population synthesized the two proteins simultaneously. To investigate whether some form of interaction between T and B cells might influence the relative quantity of the two proteins synthesized, varying numbers of T cells were added to a constant number of B cells before incubation with [14C]leucine. SDS gels of the cryoprecipitates from this experiment demonstrated that the amount of either the 225,000 or 185,000 dalton protein was similar to that obtained from equal numbers of isolated T or B cells.
Further Purification of B Lymphocytes. The B-cell enriched fraction, obtained by double rosette sedimentation depletion of T cells, contained 70-80% SIg + cells, 3-7% monocytes, and 10-15% iymphocytes which were E-and SIg-. To obtain a more homogeneous population of B-lymphocytes, PBL were separated into subpopulations by fractionation on anti-human-Fab Sephadex G-200 columns. Utilizing this technique along with monocyte depletion by adherence to plastic Petri dishes, 98% SIg + cells were obtained. Cold precipitated lysates from the unbound cell fraction (T and N) synthesized both the 225,000 and the 185,000 dalton macromolecules (Fig. 3a) , while equal numbers of viable B lymphocytes from the anti-Fab column did not synthesize either protein (Fig. 3b) . To be certain that these B lymphocytes were capable of protein synthesis, radiolabeled lysates were shown to synthesize IgM when analyzed on SDS-PAGE (not shown). Although the T cells obtained by the anti-Fab columns contain 80-85% E + cells and less than 2% SIg ÷ cells, there is a substantial number of cells that are E-and SIg-, referred to as N cells (21) . To establish whether the 185,000 dalton macromolecule was the product of this N-cell population, unbound cells from the anti-Fab column were rosetted with SRBC and subjected to FHC. The radiolabeled lymphocytes from the SRBC pellet (98% E ÷) were lysed, cold precipitated, and subjected to SDS-PAGE. These T cells again demonstrated the 225,000 dalton component, while the N cells, at the Ficoll-medium interphase, synthesized the 185,000 dalton protein ( Fig. 4a and 4b) . The N cells consisted of less than 2% E + cells and less than 1% SIg + lymphocytes.
Further proof of the N-cell origin of the smaller protein was obtained in the following experiment. PBL were subjectocl to double rosette sedimentation with SRBC to deplete the T-cells. An aliquot of the Ficoll-medium interphase cells was radiolabeled and the remainder applied to anti-human-Fab columns. Bound and u n b o u n d cells were also radiolabeled and all lysates cold precipitated and analyzed on SDS-PAGE. The interphase cells, i.e., B enriched cells, demonstrated a single peak of radioactivity of 185,000 daltons. T h e unbound, N cells, synthesized a radioactive peak of the same mobility, while no cold insoluble radioactive peak was found in the eluted B-cell fraction. The N cells were less than 2% SIg ÷ and less than 1% E ÷. These two proteins are referred to as T -M I C G (225,000 daltons) and N -M I C G (185,000 daltons). The same sequence of experiments, performed on lymphocytes obtained from three other individuals, yielded identical results to those above.
Immunological Analysis of Human Ctyoproteins.
On immunoelectrophoresis anti-Cr + N ) -M I C G antiserum showed two precipitan arcs of/~-mobility against PBL lysates, but did not react with whole h u m a n plasma or serum. This antiserum showed single precipitan arcs against purified T -M I C G and purified N-MICG. Similar results were obtained in Ouchterlony analysis. Antiserum to purified T -M I C G gave a single When an unwashed cold precipitate from PBL is subjected to SDS-PAGE and stained for protein, a number of bands are seen, in addition to T-MICG and N-MICG (not shown). In contrast, thorough washing of the cold precipitate, before dissolving for SDS-PAGE, reveals only two bands (Fig. 2 a) . The other protein bands, deliberately produced by incomplete washing of the cryoprecipitate, would serve as a control for determining the specificity of the antisera. Accordingly, unwashed precipitates from PBL were dissolved in Triton-urea and radioiodinated. The radiolabeled proteins were immune precipitated with one antiserum and the supernate tested for reactivity with a second antiserum. The precipitates were analyzed on SDS-PAGE. The results in Fig. 5 demonstrate that antiserum to T-MICG only precipitated the larger (225,000 dahons) of these two proteins (Fig. 5a ), while antiserum to N-MICG only reacted with the smaller (185,000 dahons) protein (Fig. 5b) . Furthermore, anti-(T + N)-MICG antiserum precipitated both of these components from the radiolabeled lysates (Fig. 5c) . In these studies, the first antiserum totally depleted the supernate of the component to which it was reactive. Normal rabbit serum had no effect on these radioiodinated proteins (Fig. 5 c) .
Cytotoxicity Induced by Antiserum to MICG. The expression of these antigens on the cell surface was examined by means of antibody induced cytotoxicity. In the experiments shown in Fig. 6 , PBL, or cells fractionated on anti-Fab columns were reacted with dilutions of antiserum in the presence of complement. Anti-T-MICG antiserum, to a titer of 1:256, induced 80% cytotoxicity of PBL, while anti-N-MICG and normal rabbit serum were not cytotoxic to PBL, beyond a titer of 1:4. When unbound cells (T + N), from anti-Fab column fractionated PBL, were treated with anti-or + N)-MICG antiserum, to a titer of 1:128, 98% of the cells were killed (Fig. 6) . In contrast, anti-CI" + N)-MICG was not cytotoxic, beyond 1:2, to B cells eluted from the antiFab column.
Cell Surface Distribution of MICG. Immunofluorescent studies employing anti-or + N)-MICG antibody revealed that 85-88% of PBL displayed a ringed fluorescent pattern (Fig. 7) . If the first antibody in indirect immunofluorescence was rabbit antihuman IgM, 12% of PBL were positively stained. Similar numbers of SIg + cells were found with the direct technique. It was also shown that the Fab2 T-fragment of anti-(T + N)-MICG antibody stained 85% of PBL in a ringed fluorescent pattern. Furthermore, anti-T-MICG antiserum stained 78-80% of PBL. The anti-(T + N)-MICG pattern was completely inhibited by absorption with the unbound cell fraction (T + N) from an anti-Fab column, as well as by isolated T and N-MICG antigen. There was no loss of immunofluorescence when the antibody was adsorbed with purified B cells, or lyophilized human plasma. Further evidence for the absence of either T or N-MICG antigen from the surface of B cells was provided using anti-Fab column purified lymphocytes. The unbound fraction demonstrated uniform ringed fluorescence (98-100%) with anti-C I" + N)-MICG antibody, while only 1-2% of these Discussion This paper details observations of a human protein, MICG, which is synthesized in human T cells. The name T-MICG was derived from its major biochemical characteristics: the protein is a macromoleeule with a tool wt of 225,000 daltons, is insoluble in the cold in nonionic detergents, has the mobility of a fl-globulin on electrophoresis and is synthesized by T cells. We have previously applied the term MICG to a similar protein found in mouse T cells (12, 13) . Preliminary evidence suggests cross-reactivity between T-MICG from mouse and human lymphocytes. We have further described another macromolecule, N-MICG, which has a mol wt of 185,000 dahons, appears to be antigenically distinct from T-MICG and is synthesized in N Cells. The term N-MICG has been employed, because the physicochemical properties of this protein are similar to T-MICG.
Evidence for the divergent cell origin of these two proteins was provided by cell separation techniques utilizing E rosette sedimentation. This revealed that the T cells synthesized the 225,000 dalton protein, while the B-enriched fraction produced the 185,000 dalton macromolecule. Analysis of cell homogeneity revealed that the T cells were 97% E +, while the B-enriched cells contained 75% SIg + cells. When the B cells obtained by rosette sedimentation were applied to anti-Fab columns, the 185,000 dalton protein was found to be a product of the N cells and not the B lymphocytes. In these latter cell preparations, the B ceils were 98% SIg ÷, while the N cells contained less than 2% SIg + cells and less than 1% E + cells (SIg-, E-). Furthermore, when PBL were applied directly to anti-Fab columns, neither form of MICG was synthesized in the eluted B cells. In contrast, the unbound ceils, containing T and N cells, synthesized the two components. When this latter cell fraction was rosette sedimented the 225,000 dalton component was synthesized in the T cells and the 185,000 dalton component synthesized in the N-cell fraction.
Although the cell of origin ofT and N-MICG differed, it remained to be determined whether these proteins were antigenically dissimilar. The evidence obtained by Ouchterlony analysis suggested, but did not prove, antigenic diversity. Further support of their antigenic uniqueness was established by utilizing radioiodinated, partially purified T and N-MICG. These experiments showed that antiserum to T-MICG precipitated the larger macromolecule (225,000 dalton), while the smaller (185,000 dalton) component remained in the supernatant. On the other hand, antiserum to N-MICG precipitated the smaller component, while the larger protein remained in the supernatant. During early studies with human MICG, we were unable to resolubilize the cryoproteins in aqueous buffers, including those containing 6 M quanidine or 8 M urea, regardless of reduction and alkylation. MICG was also not completely soluble in either NP-40 or Triton X-100 at concentrations from 0.1% to 5% (vol/vol), i.e., only 30% of the cryoprotein was soluble in 0.5% Triton X-100. The marked insolubility of these proteins in cold solutions necessitated resolubilization in 0.01% SDS or 0.5% Triton-2 M urea in which 100% of the cryoprotein was soluble. Furthermore, partially purified preparations were used and therefore monospecificity of antiserum could not be completely established. However, recent experiments, addressing this question, have clearly demonstrated the antigenic dissimilarity of T and N-MICG.
Studies employing antibody induced cytotoxicity suggested the presence of T and N-MICG on the lymphocyte plasma membrane. Cytotoxicity experiments utilizing anti-T-MICG antiserum demonstrated that T-MICG was present on the plasma membrane of 80% of PBL. The lack of effect on antiserum to N-MICG on PBL may have been due to the small number of N cells, i.e., 4-10% in PBL. In immunofluorescent experiments, to be separately reported, we have shown that N-MICG is present on the plasma membrane of 4-7% of PBL, which are E-and SIg-. 2 When cytotoxicity of T and N cells was induced by anti-(T + N)-MICG the percent killed cells was 98%, compared to 80% for PBL. This difference can be accounted for by the absence of B cells in the T and N-cell fraction. Furthermore, this antiserum was not cytotoxic to B cells.
Direct evidence of the plasma membrane nature of these antigens was provided by immunofluorescence examination. These studies clearly showed that T, and probably N-MICG, were located on the plasma membrane of T and N cells, respectively, but not on B-cells. In addition, we have shown that T-MICG can be capped by incubation of PBL with anti-T-MICG antiserum for 30 min at 37°C. Although these experiments suggest that neither T-MICG nor N-MICG are found on most B lymphocytes, it is possible that one of these proteins is present on a small subpopulation of B cells. The B-cell fraction from the anti-Fab column did contain 4% MICG-positive cells. We are currently examining PBL by combined immunofluorescence with FITC conjugated anti-N-MICG antiserum and rhodamine conjugated anti-Ig antiserum to determine whether a subpopulation of B-cells has both N-MICG and Ig on their surface.
In the mouse, T lymphocytes can be clearly distinguished from other lymphocyte subpopulations by virtue of a number of well defined surface markers (5-7). Mouse T cells have Thy 1.2 antigen and Ly antigens. B cells in both man and mouse are typified by cell surface immunoglobulin (1) (2) (3) (4) . In contrast, human T cells have few well characterized surface antigens. The SRBC rosette receptor has partially been characterized, while the HTLA antigen has been defined by serological methods (8) (9) (10) . Our results suggest that human T cells can be distinguished by virtue of the presence of a new antigenic marker, i.e., T-MICG. Furthermore, N cells, defined as E-, SIg-, can also be characterized by virtue of another protein, N-MICG. Although a fraction of N cells in man display the B-cell antigen (equivalent to mouse Ia, immune response associated antigen), this antigen is also found on B lymphocytes (35) (36) (37) (38) (39) . In contrast, N-MICG is not found on either T or B-cell populations.
Further studies are in progress in our laboratory to determine the biological significance of these proteins.
Summary
Although surface immunoglobulin characterizes B cells in man, there are few surface markers that distinguish T cells. We have described a new protein synthesized in human T cells, termed T-MICG. This protein is a macromolecule of 225,000 dahons, is insoluble in the cold, and migrates as a /~-globulin on electrophoresis. Separation of human peripheral blood lymphocytes into T and B-cell populations by z S. P. Hauptman et al. Manuscript in preparation.
rosette sedimentation and anti-human-Fab columns clearly demonstrated the T-cell origin of the 225,000 dalton component. Furthermore, null cells were shown to synthesize a protein of 185,000 daltons, termed N-MICG, with physical properties similar to T-MICG. T-MICG and N-MICG were shown to be antigenically dissimilar, employing antiserum to each of these proteins. The present studies demonstrate two novel cell surface markers, T-MICG and N-MICG, which characterize T cells and null cells, respectively.
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